Novel KIR2DS4:HLA-B∗35 interaction predicts HLA-B∗35+ patient survival after hematopoietic stem cell transplant
Blood Advances
· Elsevier
Аннотация
Publication date: 24 November 2026 Source: Blood Advances, Volume 10, Issue 22 Author(s): Stephen Gottschalk, Ying Li, Subodh Selukar, Alison M. Kirk, Swati Naik, Daniel Fürst, Sophie Mannes, Sarah Flossdorf, Jan Beyersmann, Hubert Schezenmeier, Georg-Nikolaus Franke, the DRST Investigators, Paul G. Thomas, Brandon M. Triplett, Peter J. Chockley
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Гематология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Novel KIR2DS4:HLA-B∗35 interaction predicts HLA-B∗35+ patient survival after hematopoietic stem cell transplant. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926006804?dgcid=rss_sd_all
Novel KIR2DS4:HLA-B∗35 interaction predicts HLA-B∗35+ patient survival after hematopoietic stem cell transplant. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926006804?dgcid=rss_sd_all
“Novel KIR2DS4:HLA-B∗35 interaction predicts HLA-B∗35+ patient survival after hematopoietic stem cell transplant.” Blood Advances.
@article{article106839,
title = {Novel KIR2DS4:HLA-B∗35 interaction predicts HLA-B∗35+ patient survival after hematopoietic stem cell transplant},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926006804?dgcid=rss_sd_all}
}